Cytokinetics, Incorporated (CYTK)
NASDAQ·Healthcare·Biotechnology
$61.10
-0.81%
Mkt Cap $8.16B
Analyst Ratings
Buy
19
Hold
1
Sell
0
Price Target (43 analysts)
$92.50
Range $69.00 – $136.00
Implied Upside
+51.4%
Consensus $92.50 vs current $61.10
NASDAQ·Healthcare·Biotechnology
$61.10
-0.81%
Mkt Cap $8.16B
Buy
19
Hold
1
Sell
0
Price Target (43 analysts)
$92.50
Range $69.00 – $136.00
+51.4%
Consensus $92.50 vs current $61.10